The forecast for France's imports of penicillins or streptomycins not in dosage forms indicates a continuous decline from 2024 to 2028. Starting at 4.4661 million USD in 2024, the value decreases each year until it reaches 1.0518 million USD in 2028. The year-on-year percentage decrease suggests a noticeable downward trend in demand or usage of these raw antibiotic products. This suggests a potential market contraction or a shift towards alternative sources or substitutes.

Future trends to watch for:

Possible shifts in pharmaceutical manufacturing practices that could affect raw antibiotic imports.
Regulatory changes in the EU that could impact import levels.
Advancements in alternative antibiotic solutions potentially reducing dependency on these compounds.